BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

993 related articles for article (PubMed ID: 16860716)

  • 21. Xenotransplantation of solid organs in the pig-to-primate model.
    Ekser B; Rigotti P; Gridelli B; Cooper DK
    Transpl Immunol; 2009 Jun; 21(2):87-92. PubMed ID: 18955143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro investigation of pig cells for resistance to human antibody-mediated rejection.
    Hara H; Long C; Lin YJ; Tai HC; Ezzelarab M; Ayares D; Cooper DK
    Transpl Int; 2008 Dec; 21(12):1163-74. PubMed ID: 18764834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mean xenograft survival of 14.6 days in a small group of hDAF-transgenic pig hearts transplanted orthotopically into baboons.
    Brenner P; Schmoeckel M; Wimmer C; Eder V; Rucker A; Felbinger T; Uchita S; Hinz M; Brandl U; Meiser B; Reichenspurner H; Hammer C; Reichart B
    Transplant Proc; 2005; 37(1):472-6. PubMed ID: 15808680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells.
    Saethre M; Baumann BC; Fung M; Seebach JD; Mollnes TE
    Transplantation; 2007 Jul; 84(2):244-50. PubMed ID: 17667817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase).
    Ramírez P; Montoya MJ; Ríos A; García Palenciano C; Majado M; Chávez R; Muñoz A; Fernández OM; Sánchez A; Segura B; Sansano T; Acosta F; Robles R; Sánchez F; Fuente T; Cascales P; González F; Ruiz D; Martínez L; Pons JA; Rodríguez JI; Yélamos J; Cowan P; d'Apice A; Parrilla P
    Transplant Proc; 2005 Nov; 37(9):4103-6. PubMed ID: 16386637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts.
    Shimizu A; Yamada K; Yamamoto S; Lavelle JM; Barth RN; Robson SC; Sachs DH; Colvin RB
    J Am Soc Nephrol; 2005 Sep; 16(9):2732-45. PubMed ID: 16049072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
    Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
    Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
    Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
    Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
    Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
    Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical xenotransplantion--how close are we?
    Cooper DK
    Lancet; 2003 Aug; 362(9383):557-9. PubMed ID: 12932390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressed complement activation in human decay accelerating factor transgenic porcine liver cross-circulated with nonhuman primates.
    Matsushita T; Ikai I; Nishitai R; Katsura N; Yamanokuchi S; Matsuo K; Sugimoto S; Shiotani T; Takahashi R; Terajima H; Yamaoka Y
    Transplantation; 2003 Jun; 75(11):1807-12. PubMed ID: 12811238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of human ABO blood groups on human xenoreactive antibody-mediated cytotoxicity and the protective effect of human decay-accelerating factors exogene on swine endothelium.
    Lee JM; Tu CF; Tai HC; Chou NK; Weng CN; Lee YC; Lee PH
    Transplant Proc; 2008 Mar; 40(2):551-3. PubMed ID: 18374126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days.
    Ramirez P; Chavez R; Majado M; Munitiz V; Muñoz A; Hernandez Q; Palenciano CG; Pino-Chavez G; Loba M; Minguela A; Yelamos J; Gago MR; Vizcaino AS; Asensi H; Cayuela MG; Segura B; Marin F; Rubio A; Fuente T; Robles R; Bueno FS; Sansano T; Acosta F; Rodriguez JM; Navarro F; Cabezuelo J; Cozzi E; White DJ; Calne RY; Parrilla P
    Transplantation; 2000 Oct; 70(7):989-98. PubMed ID: 11045632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic animals in experimental xenotransplantation models: orthotopic heart transplantation in the pig-to-baboon model.
    Brandl U; Michel S; Erhardt M; Brenner P; Burdorf L; Jöckle H; Bittmann I; Rössle M; Mordstein V; Baschnegger H; Bauer A; Hammer C; Reichart B; Schmoeckel M
    Transplant Proc; 2007 Mar; 39(2):577-8. PubMed ID: 17362786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation.
    Bühler L; Yamada K; Kitamura H; Alwayn IP; Basker M; Appel JZ; Colvin RB; White-Scharf ME; Sachs DH; Robson SC; Awwad M; Cooper DK
    Transplantation; 2001 Dec; 72(11):1743-52. PubMed ID: 11740383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced fibrin deposition and intravascular thrombosis in hDAF transgenic pig hearts perfused with tirofiban.
    Brandl U; Jöckle H; Erhardt M; Michel S; Burdorf L; Brenner P; Bittmann I; Rössle M; Mordstein V; Hammer C; Thein E; Reichart B; Schmoeckel M
    Transplantation; 2007 Dec; 84(12):1667-76. PubMed ID: 18165780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of GAS914 in an orthotopic pig-to-baboon heart transplantation model.
    Brandl U; Michel S; Erhardt M; Brenner P; Bittmann I; Rössle M; Baschnegger H; Bauer A; Hammer C; Schmoeckel M; Reichart B
    Xenotransplantation; 2005 Mar; 12(2):134-41. PubMed ID: 15693844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in xenotransplantation.
    Cozzi E; Masroor S; Soin B; Vial C; White DJ
    Clin Nephrol; 2000 Apr; 53(4):suppl 13-8. PubMed ID: 10809429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of the xenoantigenicity of neonatal porcine islet-like cell clusters (NPCC) and the efficiency of adenovirus-mediated DAF (CD55) expression.
    Omori T; Nishida T; Komoda H; Fumimoto Y; Ito T; Sawa Y; Gao C; Nakatsu S; Shirakura R; Miyagawa S
    Xenotransplantation; 2006 Sep; 13(5):455-64. PubMed ID: 16925670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.